Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Flare of Rheumatic Disease After SARS-CoV-2 Vaccination: A Review
Yan Xie, Yang Liu, Yi Liu
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Self‐Reported Delayed Adverse Events and Flare Following COVID‐19 Vaccination Among Patients With Autoimmune Rheumatic Disease (AIRD) in Malaysia: Results From the COVAD‐2 Study
Syahrul Sazliyana Shaharir, Azmawati Mohammed Nawi, Theepa Nesam Mariamutu, et al.
International Journal of Rheumatic Diseases (2025) Vol. 28, Iss. 1
Closed Access | Times Cited: 1
Safety profile of recombinant adjuvanted anti-herpes zoster vaccine (RZV) in high-risk groups: Data from active surveillance program. Puglia (Italy), 2021–23
Pasquale Stefanizzi, Lorenza Moscara, Claudia Palmieri, et al.
Vaccine (2024) Vol. 42, Iss. 12, pp. 2966-2974
Open Access | Times Cited: 6
Long-Term Safety Analysis of the ChAdOx1-nCoV-19 Corona Virus Vaccine: Results from a Prospective Observational Study in Priority Vaccinated Groups in North India
Upinder Kaur, Zeba Fatima, Kalika Maheshwari, et al.
Drug Safety (2023) Vol. 46, Iss. 6, pp. 553-563
Open Access | Times Cited: 15
Factors associated with immune responses to SARS-CoV-2 vaccination in autoimmune disease individuals
Erik Anderson, Michael D. Powell, Emily Yang, et al.
JCI Insight (2024) Vol. 9, Iss. 13
Open Access | Times Cited: 4
COVID-19 vaccination in patients on biologic or targeted-synthetic disease modifying anti-rheumatic drug therapy: A multi center real-world data
Tuba Demirci Yıldırım, Cansu Akleylek, Derya Yıldırım, et al.
Asian Pacific Journal of Tropical Medicine (2025) Vol. 18, Iss. 2, pp. 77-83
Open Access
Flares in IIMs and the timeline following COVID-19 vaccination: a combined analysis of the COVAD-1 and -2 surveys
R Naveen, Parikshit Sen, Zoltán Griger, et al.
Lara D. Veeken (2023) Vol. 63, Iss. 1, pp. 127-139
Open Access | Times Cited: 10
COVID-19 risk perception and vaccine acceptance in individuals with self-reported chronic respiratory or autoimmune conditions
Brianna Smith, Emily Ricotta, Jennifer Kwan, et al.
Allergy Asthma and Clinical Immunology (2023) Vol. 19, Iss. 1
Open Access | Times Cited: 10
Disproportionality analysis of European safety reports on autoimmune and rheumatic diseases following COVID-19 vaccination
Federica Fraenza, Cecilia Cagnotta, Mario Gaio, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Treatment Options in Pediatric Behçet’s Disease
Teresa Giani, Angela Luppino, Giovanna Ferrara
Pediatric Drugs (2023) Vol. 25, Iss. 2, pp. 165-191
Open Access | Times Cited: 9
The Third Dose of BNT162b2 COVID-19 Vaccine Does Not “Boost” Disease Flares and Adverse Events in Patients with Rheumatoid Arthritis
Andrea Picchianti Diamanti, Assunta Navarra, Gilda Cuzzi, et al.
Biomedicines (2023) Vol. 11, Iss. 3, pp. 687-687
Open Access | Times Cited: 9
Immune responses and disease biomarker long-term changes following COVID-19 mRNA vaccination in a cohort of rheumatic disease patients
Zesheng An, Gabriel Figueroa‐Parra, Xian Zhou, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
Prevalence and factors associated with flares following COVID-19 mRNA vaccination in patients with rheumatoid arthritis, psoriatic arthritis and spondyloarthritis: a national cohort study
Warren Fong, Ting Hui Woon, Li‐Ching Chew, et al.
Advances in Rheumatology (2023) Vol. 63, Iss. 1
Open Access | Times Cited: 8
Differential cellular and humoral immune responses in immunocompromised individuals following multiple SARS-CoV-2 vaccinations
Rhys T Meredith, Max D Bermingham, Kirsten Bentley, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 7
Breakthrough SARS-CoV-2 infection and disease flares in patients with rheumatoid arthritis: result from COVAD e-survey study
C. Sieiro Santos, J. P. Chen, Elena Nikiphorou, et al.
Rheumatology International (2024) Vol. 44, Iss. 5, pp. 805-817
Closed Access | Times Cited: 2
Should we stop methotrexate or not for vaccination?
Patrick Durez, Bernard Combe
RMD Open (2023) Vol. 9, Iss. 2, pp. e002798-e002798
Open Access | Times Cited: 5
COVID-19 and rheumatic diseases: A mini-review
Livia Roseti, Brunella Grigolo
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 8
Outcomes in children with rheumatic diseases following COVID-19 vaccination and infection: data from a large two-center cohort study in Thailand
Butsabong Lerkvaleekul, Sirirat Charuvanij, Maynart Sukharomana, et al.
Frontiers in Pediatrics (2023) Vol. 11
Open Access | Times Cited: 4
Clinical and immunological responses to COVID-19 vaccination in rheumatoid arthritis patients on disease modifying antirheumatic drugs: a cross-sectional study
Madhavi Eerike, Vijaya Prasanna Parimi, Anand Pyati, et al.
Journal of Rheumatic Diseases (2023) Vol. 31, Iss. 1, pp. 15-24
Open Access | Times Cited: 4
Safety of COVID-19 Vaccine in Patients with Rheumatic and Musculoskeletal Diseases
Ali Abdulrahman Younis, Asal Adnan Ridha, Yasameen Abbas Humadi, et al.
Mediterranean Journal of Rheumatology (2024) Vol. 35, Iss. 1, pp. 123-123
Open Access | Times Cited: 1
COVID-19 vaccine updates for people under different conditions
Yi-Jiao Huang, Weiyang Wang, Yan Liu, et al.
Science China Life Sciences (2024) Vol. 67, Iss. 11, pp. 2323-2343
Closed Access | Times Cited: 1
Association between COVID-19 infection and uveitis flare in patients with Behcet’s disease, a retrospective multicenter cohort study
Hang Song, Yuelun Zhang, Ying Chen, et al.
Graefe s Archive for Clinical and Experimental Ophthalmology (2024)
Closed Access | Times Cited: 1
Symptom flares after COVID-19 infection versus vaccination among youth with PANS/PANDAS
Maria D. LaRusso, C. Abadía
Allergy and Asthma Proceedings (2023) Vol. 44, Iss. 5, pp. 361-367
Open Access | Times Cited: 3
COVID-19 vaccination and infection status: a cross-sectional survey of patients with rheumatic diseases in China
Chen Chen, S. Huang, Linyu Geng, et al.
Rheumatology International (2023) Vol. 44, Iss. 4, pp. 703-713
Closed Access | Times Cited: 3
Should we vaccinate during an active rheumatic disease?
Marc Bijl, Johanna Westra, Silvia Mancuso, et al.
Autoimmunity Reviews (2023) Vol. 23, Iss. 1, pp. 103426-103426
Open Access | Times Cited: 2
Long-term outcomes of COVID-19 vaccination in patients with rare and complex connective tissue diseases: The ERN-ReCONNET VACCINATE study
Chiara Tani, Chiara Cardelli, Roberto Depascale, et al.
Journal of Translational Autoimmunity (2023) Vol. 7, pp. 100221-100221
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top